RxSight Inc. announced that Chief Financial Officer Shelley Thunen will transition from her role, remaining with the company until her successor is appointed or until January 31, 2026. Thunen will continue to support RxSight as a consultant following the transition.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RxSight Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9616224-en) on December 22, 2025, and is solely responsible for the information contained therein.
Comments